Daniel A Haber

13PUBLICATIONS
98CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 17, 2026
Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

|Jan 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Avanish Mishra, Catherine B Meador, Kruthika Kikkeri

|Aug 06, 2025
The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.

Joanna A Vuille, Cem Tanriover, Ezgi Antmen

|Jul 07, 2025
CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors.

Elad Horwitz, Taronish D Dubash, Annamaria Szabolcs

|Jan 02, 2025
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product.

Avanish Mishra, Shih-Bo Huang, Taronish Dubash

|Nov 01, 2024
Combination Diagnostics: Adding Blood-Based ctDNA Screening to Low-Dose CT Imaging for Early Detection of Lung Cancer.

Daniel A Haber, Steven J Skates

Pageof 3

Frequent Collaborators

5 joint publications

David T Ting

4 joint publications

Richard Y Ebright

4 joint publications

Ben S Wittner

4 joint publications

Shyamala Maheswaran